{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T20:27:47Z","timestamp":1790972867408,"version":"4.1.0"},"reference-count":29,"publisher":"Oxford University Press (OUP)","issue":"10","license":[{"start":{"date-parts":[[2010,10,1]],"date-time":"2010-10-01T00:00:00Z","timestamp":1285891200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2010,10,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Aim<\/jats:title>\n                    <jats:p>Marfan syndrome (MFS) is an inherited connective tissue disease which frequently involves the cardiovascular system. The heart can be affected since valvular regurgitation is a common complication. However, there is still debate whether a primary cardiomyopathy exists. Our aim was to evaluate the existence of a Marfan-related cardiomyopathy using cardiovascular magnetic resonance.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods and results<\/jats:title>\n                    <jats:p>We retrospectively evaluated 68 consecutive adult patients with no cardiovascular surgery or significant valvular regurgitation. Left ventricular and right ventricular volumes, ejection fraction, and mass were estimated and compared with published data on a healthy control population. Patients were also assessed for heart failure, aortic dimensions, and valve disease.<\/jats:p>\n                    <jats:p>One quarter (25.0%) of Marfan patients had reduced left ventricular ejection fraction (LVEF), with 25.0% having increased left ventricular end-diastolic and 30.8% having increased end-systolic volumes. The right ventricular ejection fraction was reduced in 10.3%, with increased right ventricular end-diastolic volumes in 11.8% and increased end-systolic volumes in 13.2%. On univariate analysis, no association was found between reduced LVEF and age, gender, indexed aortic dimensions, presence of mitral valve prolapse, or valve regurgitation.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>This study supports the existence of a primary cardiomyopathy in a subgroup of Marfan patients. The biventricular enlargement and dysfunction is usually mild, asymptomatic, and independent from other cardiovascular manifestations. Further studies are needed to assess underlying causes and natural history of this condition. Routine monitoring and treatment in MFS may need to be tailored not only to prevent aortic root expansion but also to support myocardial function.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/eurjhf\/hfq127","type":"journal-article","created":{"date-parts":[[2010,9,22]],"date-time":"2010-09-22T12:48:40Z","timestamp":1285159720000},"page":"1085-1091","source":"Crossref","is-referenced-by-count":120,"title":["Evidence for Marfan Cardiomyopathy"],"prefix":"10.1093","volume":"12","author":[{"given":"Francisco","family":"Alpendurada","sequence":"first","affiliation":[{"name":"Royal Brompton & Harefield NHS Foundation Trust , London ,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joyce","family":"Wong","sequence":"additional","affiliation":[{"name":"Royal Brompton & Harefield NHS Foundation Trust , London ,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anatoli","family":"Kiotsekoglou","sequence":"additional","affiliation":[{"name":"St George's University of London , London ,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Winston","family":"Banya","sequence":"additional","affiliation":[{"name":"Royal Brompton & Harefield NHS Foundation Trust , London ,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne","family":"Child","sequence":"additional","affiliation":[{"name":"St George's University of London , London ,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sanjay K.","family":"Prasad","sequence":"additional","affiliation":[{"name":"Royal Brompton & Harefield NHS Foundation Trust , London ,","place":["UK"]},{"name":"National Heart and Lung Institute, Imperial College London , London ,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dudley J.","family":"Pennell","sequence":"additional","affiliation":[{"name":"Royal Brompton & Harefield NHS Foundation Trust , London ,","place":["UK"]},{"name":"National Heart and Lung Institute, Imperial College London , London ,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raad H.","family":"Mohiaddin","sequence":"additional","affiliation":[{"name":"Royal Brompton & Harefield NHS Foundation Trust , London ,","place":["UK"]},{"name":"National Heart and Lung Institute, Imperial College London , London ,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2014,1,13]]},"reference":[{"key":"2026020203325390000_ejhfhfq127-bib-0001","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1056\/NEJM197904053001406","article-title":"The Marfan syndrome: diagnosis and management","volume":"300","author":"Pyeritz","year":"1979","journal-title":"N Engl J Med"},{"key":"2026020203325390000_ejhfhfq127-bib-0002","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1016\/j.gde.2007.04.006","article-title":"Marfan syndrome: from molecular pathogenesis to clinical treatment","volume":"17","author":"Ramirez","year":"2007","journal-title":"Curr Opin Genet Dev"},{"key":"2026020203325390000_ejhfhfq127-bib-0003","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1002\/(SICI)1096-8628(19960424)62:4<417::AID-AJMG15>3.0.CO;2-R","article-title":"Revised diagnostic criteria for the Marfan syndrome","volume":"62","author":"De Paepe","year":"1996","journal-title":"Am J Med Genet"},{"key":"2026020203325390000_ejhfhfq127-bib-0004","first-page":"1965","article-title":"Marfan's syndrome","volume":"366","author":"Judge","journal-title":"Lancet 2005"},{"key":"2026020203325390000_ejhfhfq127-bib-0005","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1016\/0735-1097(95)00258-0","article-title":"Family history of severe cardiovascular disease in Marfan syndrome is associated with increased aortic diameter and decreased survival","volume":"26","author":"Silverman","year":"1995","journal-title":"J Am Coll Cardiol"},{"key":"2026020203325390000_ejhfhfq127-bib-0006","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1016\/0022-2828(90)90087-I","article-title":"Spatial arrangements of microfibrils in myocardial scars: application of antibody to fibrillin","volume":"22","author":"Vracko","year":"1990","journal-title":"J Mol Cell Cardiol"},{"key":"2026020203325390000_ejhfhfq127-bib-0007","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1536\/ihj.26.1043","article-title":"Myocardial involvement in the Marfan syndrome","volume":"26","author":"Fujiseki","year":"1985","journal-title":"Jpn Heart J"},{"key":"2026020203325390000_ejhfhfq127-bib-0008","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/0002-9149(89)90338-X","article-title":"Comparison of cardiovascular and skeletal features of primary mitral valve prolapse and Marfan syndrome","volume":"63","author":"Roman","year":"1989","journal-title":"Am J Cardiol"},{"key":"2026020203325390000_ejhfhfq127-bib-0009","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1093\/oxfordjournals.eurheartj.a060558","article-title":"Left ventricular function in children with the Marfan syndrome","volume":"15","author":"Savolainen","year":"1994","journal-title":"Eur Heart J"},{"key":"2026020203325390000_ejhfhfq127-bib-0010","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1016\/S0002-9149(03)00039-0","article-title":"Left ventricular function in the Marfan syndrome without significant valvular regurgitation","volume":"91","author":"Chatrath","year":"2003","journal-title":"Am J Cardiol"},{"key":"2026020203325390000_ejhfhfq127-bib-0011","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1016\/j.amjcard.2004.11.042","article-title":"Evaluation of left ventricular dimensions and function in Marfan's syndrome without significant valvular regurgitation","volume":"95","author":"Meijboom","year":"2005","journal-title":"Am J Cardiol"},{"key":"2026020203325390000_ejhfhfq127-bib-0012","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/j.ijcard.2005.10.010","article-title":"Primary impairment of left ventricular function in Marfan syndrome","volume":"112","author":"De Backer","year":"2006","journal-title":"Int J Cardiol"},{"key":"2026020203325390000_ejhfhfq127-bib-0013","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1007\/s00246-005-1139-5","article-title":"Left ventricular diastolic dysfunction in children and young adults with Marfan syndrome","volume":"27","author":"Das","year":"2006","journal-title":"Pediatr Cardiol"},{"key":"2026020203325390000_ejhfhfq127-bib-0014","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1002\/clc.3","article-title":"Tissue Doppler imaging identifies myocardial dysfunction in adults with Marfan syndrome","volume":"30","author":"Rybczynski","year":"2007","journal-title":"Clin Cardiol"},{"key":"2026020203325390000_ejhfhfq127-bib-0015","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1093\/ejechocard\/jen003","article-title":"Early impairment of left ventricular long-axis systolic function demonstrated by reduced atrioventricular plane displacement in patients with Marfan syndrome","volume":"9","author":"Kiotsekoglou","year":"2008","journal-title":"Eur J Echocardiogr"},{"key":"2026020203325390000_ejhfhfq127-bib-0016","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1093\/ejechocard\/jep110","article-title":"Biventricular and atrial diastolic function assessment using conventional echocardiography and tissue-Doppler imaging in adults with Marfan syndrome","volume":"10","author":"Kiotsekoglou","year":"2009","journal-title":"Eur J Echocardiogr"},{"key":"2026020203325390000_ejhfhfq127-bib-0017","first-page":"e82","article-title":"ACC\/AHA guidelines for the management of patients with ST-elevation myocardial infarction","volume":"110","author":"Antman","year":"2004","journal-title":"Circulation"},{"key":"2026020203325390000_ejhfhfq127-bib-0018","first-page":"e391","article-title":"2009 focused update incorporated into the ACC\/AHA 2005 Guidelines for the diagnosis and management of heart failure in adults","volume":"119","author":"Hunt","year":"2009","journal-title":"Circulation"},{"key":"2026020203325390000_ejhfhfq127-bib-0019","first-page":"e523","article-title":"2008 Focused update incorporated into the ACC\/AHA 2006 guidelines for the management of patients with valvular heart disease","volume":"118","author":"Bonow","year":"2008","journal-title":"Circulation"},{"key":"2026020203325390000_ejhfhfq127-bib-0020","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/S0002-9149(02)02381-0","article-title":"Comparison of interstudy reproducibility of cardiovascular magnetic resonance with two-dimensional echocardiography in normal subjects and in patients with heart failure or left ventricular hypertrophy","volume":"90","author":"Grothues","year":"2002","journal-title":"Am J Cardiol"},{"key":"2026020203325390000_ejhfhfq127-bib-0021","first-page":"218","article-title":"Interstudy reproducibility of right ventricular volumes, function, and mass with cardiovascular magnetic resonance","volume":"147","author":"Grothues","year":"2004","journal-title":"Am Heart J"},{"key":"2026020203325390000_ejhfhfq127-bib-0022","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1080\/10976640600572889","article-title":"Normalized left ventricular systolic and diastolic function by steady state free precession cardiovascular magnetic resonance","volume":"8","author":"Maceira","year":"2006","journal-title":"J Cardiovasc Magn Reson"},{"key":"2026020203325390000_ejhfhfq127-bib-0023","doi-asserted-by":"crossref","first-page":"2879","DOI":"10.1093\/eurheartj\/ehl336","article-title":"Reference right ventricular systolic and diastolic function normalized to age, gender and body surface area from steady-state free precession cardiovascular magnetic resonance","volume":"27","author":"Maceira","year":"2006","journal-title":"Eur Heart J"},{"key":"2026020203325390000_ejhfhfq127-bib-0024","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1081\/JCMR-200065639","article-title":"How we perform cardiovascular magnetic resonance flow assessment using phase-contrast velocity mapping","volume":"7","author":"Chai","year":"2005","journal-title":"J Cardiovasc Magn Reson"},{"key":"2026020203325390000_ejhfhfq127-bib-0025","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1161\/CIRCIMAGING.108.768911","article-title":"Aortic root measurement by cardiovascular magnetic resonance: specification of planes and lines of measurement and corresponding normal values","volume":"1","author":"Burman","year":"2008","journal-title":"Circ Cardiovasc Imaging"},{"key":"2026020203325390000_ejhfhfq127-bib-0026","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1080\/10976640600604856","article-title":"Severity of mitral and aortic regurgitation as assessed by cardiovascular magnetic resonance: optimizing correlation with Doppler echocardiography","volume":"8","author":"Gelfand","year":"2006","journal-title":"J Cardiovasc Magn Reson"},{"key":"2026020203325390000_ejhfhfq127-bib-0027","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1093\/eurheartj\/ehm342","article-title":"Classification of the cardiomyopathies: a position statement from the European Society Of Cardiology Working Group on Myocardial and Pericardial Diseases","volume":"29","author":"Elliott","year":"2008","journal-title":"Eur Heart J"},{"key":"2026020203325390000_ejhfhfq127-bib-0028","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1067\/mhj.2001.116071","article-title":"Reduced right ventricular ejection fraction as a marker for idiopathic dilated cardiomyopathy compared with ischemic left ventricular dysfunction","volume":"142","author":"La Vecchia","year":"2001","journal-title":"Am Heart J"},{"key":"2026020203325390000_ejhfhfq127-bib-0029","doi-asserted-by":"crossref","first-page":"2787","DOI":"10.1056\/NEJMoa0706585","article-title":"Angiotensin II blockade and aortic-root dilation in Marfan's syndrome","volume":"358","author":"Brooke","year":"2008","journal-title":"N Engl J Med"}],"container-title":["European Journal of Heart Failure"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1093%2Feurjhf%2Fhfq127","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/academic.oup.com\/eurjhf\/article-pdf\/12\/10\/1085\/66497646\/eurjhf_12_10_1085.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/eurjhf\/article-pdf\/12\/10\/1085\/66497646\/eurjhf_12_10_1085.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,2]],"date-time":"2026-02-02T08:33:01Z","timestamp":1770021181000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/eurjhf\/article\/12\/10\/1085\/8433808"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,10,1]]},"references-count":29,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2014,1,13]]},"published-print":{"date-parts":[[2010,10,1]]}},"URL":"https:\/\/doi.org\/10.1093\/eurjhf\/hfq127","relation":{},"ISSN":["1388-9842","1879-0844"],"issn-type":[{"value":"1388-9842","type":"print"},{"value":"1879-0844","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2010,10]]},"published":{"date-parts":[[2010,10,1]]}}}